Did you know?
You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)
Let's also keep in mind that the RVX208 (Apebetalone) patent runs out in 2027 unless it was extended, which I'm not aware of. And it may take up to 2021 before it gets to market after FDA approval. So does a buyout of $5 billion make any sense?
Does the RVX208 patent cover CKD and Cognition and does it also runs out in 2027?
Does the RVX208 patent cover any other indication?
